E-alcohol Therapy - an Evaluation of Alcohol Therapy Delivered Via Video Conference

November 27, 2024 updated by: Kia Kejlskov Egan, University of Southern Denmark
The study evaluates whether the introduction of e-alcohol therapy (alcohol therapy delivered via video conference) can break with some of the barriers related to alcohol treatment and thereby appeal to people with a problematic alcohol use (Alcohol Use Disorder Test score ≥ 8). The study aims to evaluate the effect of e-alcohol therapy on initiation, treatment compliance and alcohol intake as compared to treatment as usual .

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Background: Only a small proportion of those who have a problematic alcohol use receive treatment and compliance is low among the few that undergo treatment. If treatment more easily can be combined with everyday life and break with some of the barriers related to stigma by having a broader appeal, more people with a problematic alcohol use may seek and complete treatment. Alcohol therapy conducted via video conference may be an attractive treatment option and effective in reducing alcohol intake among people with a problematic alcohol use who do not seek traditional treatment.

Objective: The aim of this trial is to evaluate whether people with a problematic alcohol use (Alcohol Use Disorder Test score ≥ 8), who enroll in alcohol therapy delivered via video conference to a greater extent initiate as well as comply with treatment and reduce their alcohol intake compared to people allocated to standard alcohol treatment.

Design: Randomized controlled trial

Participants: 375 Danish citizens above 18 years with a problematic alcohol use (Alcohol Use Disorder Test (AUDIT) score >8).

Intervention: Participants are randomized to one of two groups:

  1. Conversational therapy via video conference where participants are contacted by an alcohol therapist for the purpose of initiating a course of treatment where participants are not required to show up at a clinic.
  2. Treatment as usual where participants receive contact information on their local alcohol treatment facility for the purpose of contacting the facility to initiate a face-to-face course of treatment at the clinic.

The allocation of participants to the intervention will be 1:1 to the intervention and the control group.

Methods: Data will be collected by questionnaire at baseline, 3 months and 12 months post randomization. Analyses will be intention to treat. Subgroup analysis will be conducted in relation to personal and demographic characteristics.

Process evaluation will be performed using a combination of questionnaires and qualitative interviews with participants, therapists and management at the clinics.

Study Type

Interventional

Enrollment (Actual)

365

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 1455
        • National Institute of Public Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

- Problematic alcohol consumption (Alcohol Use Disorder Test score ≥ 8)

Exclusion Criteria:

  • Not legally able and willing to provide informed consent
  • No provision of a functional e-mail address
  • No provision of municipality of residence and phone number
  • No access to a personal computer equipped with functional camera, audio equipment, and Internet access.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Conversational therapy via video conference where participants are contacted by an alcohol therapist for the purpose of initiating a course of therapy where participants are not required to show up at a clinic.
Conversational therapy sessions provided via video conference by a professional alcohol therapist.
Other Names:
  • Electronic alcohol therapy
No Intervention: Control
Treatment as usual where participants receive contact information on their local alcohol treatment facility for the purpose of contacting the facility to initiate a face-to-face course of treatment at the clinic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Initiation of treatment (completion of one session)
Time Frame: 3 months post randomization
25% higher completion of one treatment session
3 months post randomization
Initiation of treatment (completion of one session)
Time Frame: 12 months post randomization
25% higher completion of at least one treatment sessions
12 months post randomization
Compliance (completion of at least 3 sessions)
Time Frame: 3 months post randomization
25% higher completion of at least three treatment sessions
3 months post randomization
Compliance (completion of at least 3 sessions)
Time Frame: 12 months post randomization
25% higher completion of at least three treatment sessions
12 months post randomization
Total weekly alcohol intake (measured by Timeline follow back)
Time Frame: 3 months post randomization
Higher reduction in total weekly alcohol intake (measured by Timeline follow back) (5 units)
3 months post randomization
Total weekly alcohol intake (measured by Timeline follow back)
Time Frame: 12 months post randomization
Higher reduction in total weekly alcohol intake (measured by Timeline follow back) (5 units)
12 months post randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weekly alcohol intake below national guidelines
Time Frame: 3 and 12 months post randomization
20% increase in participants reporting a weekly alcohol intake below the national high risk drinking limits.
3 and 12 months post randomization
Weekly number of heavy drinking days
Time Frame: 3 and 12 months post randomization
Lower number of weekly heavy drinking days (5+ units in one occasion)
3 and 12 months post randomization
Weekly drinking days
Time Frame: 3 and 12 months post randomization
Lower number of weekly drinking days
3 and 12 months post randomization
Problematic drinking
Time Frame: 12 months post randomization
Lower Alcohol Use Disorder Test score
12 months post randomization
Quality of life
Time Frame: 3 and 12 months post randomization
Higher quality of life as measured by the 'Cantril Ladder'
3 and 12 months post randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Janne Tolstrup, Professor, University of Southern Denmark
  • Study Director: Ulrik Becker, Professor, University of Southern Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 22, 2018

Primary Completion (Actual)

August 1, 2021

Study Completion (Actual)

August 1, 2021

Study Registration Dates

First Submitted

March 29, 2017

First Submitted That Met QC Criteria

April 11, 2017

First Posted (Actual)

April 17, 2017

Study Record Updates

Last Update Posted (Actual)

December 3, 2024

Last Update Submitted That Met QC Criteria

November 27, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Problematic Alcohol Use

Clinical Trials on E-alcohol therapy

Subscribe